Literature DB >> 22738400

Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service.

Richard O Francis1, Jeffrey Jhang, Jeanne E Hendrickson, James C Zimring, Eldad A Hod, Steven L Spitalnik.   

Abstract

BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is characterized by red blood cell (RBC) destruction in response to oxidative stress. Although blood donors are not routinely screened for G6PD deficiency, the transfusion of stored G6PD-deficient RBCs may have serious adverse outcomes. By measuring G6PD enzyme activity of RBC units from a large metropolitan hospital transfusion service, we sought to determine 1) the prevalence of G6PD-deficient RBC units, 2) if G6PD activity changes during storage, and 3) if G6PD activity in segments correlates with its activity in the bags. STUDY DESIGN AND METHODS: Quantitative G6PD activity was measured in 301 randomly selected RBC units and 73 D+C-E- (i.e., R r or R R ) RBC units, all stored in additive solutions. G6PD deficiency was defined as activity less than 60% of the normal mean.
RESULTS: The frequency of G6PD-deficient units in the general inventory was 0.3% (1/301; 95% confidence interval [CI], <0.01%-2.1%). In contrast, its frequency in D+C-E- RBC units was 12.3% (9/73; 95% CI, 6.4%-22.0%). G6PD activity did not significantly change during the 42-day storage period, and G6PD activity measured in RBC storage bags and attached segments correlated well (r=0.7-0.9, p ≤ 0.001, Spearman rank correlation).
CONCLUSIONS: Although the frequency of G6PD-deficient RBC units in the transfusion service general inventory was relatively low, it was significantly higher among a subset of R r or R R units. The latter are preferentially allocated for transfusion to patients with sickle cell disease to decrease the risk of RBC alloimmunization, possibly allowing more of these units to be inadvertently targeted to these patients.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22738400      PMCID: PMC3461237          DOI: 10.1111/j.1537-2995.2012.03765.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  22 in total

1.  GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN RED CELLS. INCIDENCE IN THE CURA CAO POPULATION, ITS CLINICAL AND GENETIC ASPECTS.

Authors:  A VAN DER SAR; H SCHOUTEN; A M BOUDIER
Journal:  Enzymologia       Date:  1964-10-15

2.  The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.

Authors:  R J DERN; E BEUTLER; A S ALVING
Journal:  J Lab Clin Med       Date:  1954-08

3.  Genetic studies of the Seneca Indians: haptoglobins, transferrins, G-6-PD deficiency, hemoglobinopathy, color blindness, morphological traits and dermatoglyphics.

Authors:  T D Doeblin; G B Ingall; P H Pinkerton; K R Dronamraju; R M Bannerman
Journal:  Acta Genet Stat Med       Date:  1968

4.  The poststorage viability of glucose-6-phosphate dehydrogenase-deficient erythrocytes.

Authors:  A R Orlina; A M Josephson; B J McDonald
Journal:  J Lab Clin Med       Date:  1970-06

5.  Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel.

Authors:  Troy D Chinevere; Clinton K Murray; Earl Grant; Gregory A Johnson; Felix Duelm; Duane R Hospenthal
Journal:  Mil Med       Date:  2006-09       Impact factor: 1.437

Review 6.  The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.

Authors:  Ella T Nkhoma; Charles Poole; Vani Vannappagari; Susan A Hall; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2009-02-23       Impact factor: 3.039

7.  Glucose-6-phosphate dehydrogenase deficiency and blood transfusion.

Authors:  P R McCurdy; E E Morse
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

8.  Posttransfusional hemolysis in recipients of glucose-6-phosphate dehydrogenase-deficient erythrocytes.

Authors:  O Shalev; N Manny; R Sharon
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

9.  Microarray kit analysis of cytokines in blood product units and segments.

Authors:  Richard B Weiskopf; Rebecca Yau; Rosa Sanchez; Clifford Lowell; Pearl Toy
Journal:  Transfusion       Date:  2009-06-22       Impact factor: 3.157

10.  Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006.

Authors:  Edward L Murphy; Beth Shaz; Christopher D Hillyer; Patricia Carey; Brian S Custer; Nora Hirschler; Junyong Fang; George B Schreiber
Journal:  Transfusion       Date:  2009-06-23       Impact factor: 3.157

View more
  21 in total

Review 1.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

Review 2.  Protect, repair, destroy or sacrifice: a role of oxidative stress biology in inter-donor variability of blood storage?

Authors:  Angelo D'Alessandro; Kirk C Hansen; Elan Z Eisenmesser; James C Zimring
Journal:  Blood Transfus       Date:  2019-06-06       Impact factor: 3.443

3.  Metabolomics of ADSOL (AS-1) red blood cell storage.

Authors:  John D Roback; Cassandra D Josephson; Edmund K Waller; James L Newman; Sulaiman Karatela; Karan Uppal; Dean P Jones; James C Zimring; Larry J Dumont
Journal:  Transfus Med Rev       Date:  2014-02-05

4.  Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study.

Authors:  Tamir Kanias; Marion C Lanteri; Grier P Page; Yuelong Guo; Stacy M Endres; Mars Stone; Sheila Keating; Alan E Mast; Ritchard G Cable; Darrell J Triulzi; Joseph E Kiss; Edward L Murphy; Steve Kleinman; Michael P Busch; Mark T Gladwin
Journal:  Blood Adv       Date:  2017-06-27

5.  Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease.

Authors:  Eyal Sagiv; Ross M Fasano; Naomi L C Luban; Cassandra D Josephson; Sean R Stowell; John D Roback; Richard O Francis; Marianne E M Yee
Journal:  Am J Hematol       Date:  2018-02-14       Impact factor: 10.047

6.  Research opportunities in optimizing storage of red blood cell products.

Authors:  Stephen J Wagner; Simone A Glynn; Lisbeth A Welniak
Journal:  Transfusion       Date:  2013-05-15       Impact factor: 3.157

Review 7.  Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks.

Authors:  R O Francis; J S Jhang; H P Pham; E A Hod; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2013-07-02       Impact factor: 2.144

8.  Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.

Authors:  Richard O Francis; Angelo D'Alessandro; Andrew Eisenberger; Mark Soffing; Randy Yeh; Esther Coronel; Arif Sheikh; Francesca Rapido; Francesca La Carpia; Julie A Reisz; Sarah Gehrke; Travis Nemkov; Tiffany Thomas; Joseph Schwartz; Chaitanya Divgi; Debra Kessler; Beth H Shaz; Yelena Ginzburg; James C Zimring; Steven L Spitalnik; Eldad A Hod
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 9.  Impact of G6PD status on red cell storage and transfusion outcomes.

Authors:  Matthew S Karafin; Richard O Francis
Journal:  Blood Transfus       Date:  2019-07       Impact factor: 3.443

Review 10.  Stored red blood cell transfusions: iron, inflammation, immunity, and infection.

Authors:  Steven L Spitalnik
Journal:  Transfusion       Date:  2014-09-04       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.